Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Oct 21, 2024

BUY
$1.15 - $1.89 $105,339 - $173,124
91,600 New
91,600 $127,000
Q1 2023

May 03, 2023

BUY
$1.15 - $1.89 $105,339 - $173,124
91,600 New
91,600 $127,000
Q1 2022

May 12, 2022

SELL
$1.23 - $3.31 $52,398 - $141,006
-42,600 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$2.89 - $4.43 $123,114 - $188,718
42,600 New
42,600 $139,000
Q1 2021

May 17, 2021

SELL
$2.92 - $5.07 $197,976 - $343,746
-67,800 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$1.64 - $3.42 $84,952 - $177,156
51,800 Added 323.75%
67,800 $205,000
Q3 2020

Nov 13, 2020

BUY
$2.18 - $2.84 $34,880 - $45,440
16,000 New
16,000 $40,000

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.